Should stroke patients with mild or improving symptoms receive tissue plasminogen activator therapy?
Some patients with acute ischemic stroke do not receive treatment with intravenous tissue plasminogen activator (tPA) because their symptoms are mild or they show improvement; however, lack of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results